Schuchert A, Meinertz T
Medical Clinic, Department of Cardiology, University-Hospital Hamburg-Eppendorf, Hamburg, Germany.
Pacing Clin Electrophysiol. 2001 Aug;24(8 Pt 1):1234-9. doi: 10.1046/j.1460-9592.2001.01234.x.
The programmability of cardiac pacemakers enables the physician at follow-up to adjust the pacing pulse under consideration of the 100% safety margin with respect to the individual pacing threshold. The purpose of reducing the output is to prolong pacemaker longevity. The aims of this prospective, randomized trial were to compare the effects of nominal output versus a lower output on projected pacemaker longevity in single and dual chamber pacemakers. The secondary aim was to assess how many patients can be programmed to 2.5 V/0.4 ms instead of the nominal 3.5-V setting with > or = 100% safety margin. The patients received the same types of VVI or DDD pacemakers that were connected in the ventricle to the steroid-eluting, high impedance pacing lead. At the 3-month follow-up, patients with ventricular pacing thresholds < or = 0.15 ms at 2.5-V pulse amplitude were randomized to 3.5 V or 2.5 V amplitude at 0.4-ms pulse duration. Lead function and projected device longevity were assessed with the pacemaker's telemetry 6 and 12 months after implantation. Of patients implanted with a VVI pacemaker, at the 3-month follow-up, 3 patients had pacing thresholds > 0.15 ms at 2.5 V and 139 patients could be randomized. A reprogramming to a higher output was necessary in one patient. The mean percentage of ventricular pacing was about 40% throughout the study time. The programming to 2.5-V output resulted in an insignificant increase of device longevity from 117.9 +/- 18.7 months in the nominal group to 123.7 +/- 11.9 months at the 12-month follow-up (P = 0.16). Of patients implanted with a DDD pacemaker, 166 patients underwent randomization. The mean percentage of ventricular pacing was 85% in the ventricle and 35% in the atrium. The 2.5-V setting significantly prolonged pacemaker longevity from 98.1 +/- 21.3 to 112.0 +/- 13.6 months (P < 0.0001). In three (1%) patients a late increase of the pacing threshold was observed. Due to the low ventricular pacing thresholds, the 2.5-V/0.4-ms setting provided, 3 months after implantation, a > or = 100% safety margin in 99% of the patients. Programming to a lower output slightly increased projected pacemaker longevity compared to the nominal 3.5-V setting. Longevity increasedfor 5% in patients with single andfor 14% in dual chamber pulse generators.
心脏起搏器的可编程性使医生在随访时能够根据个体起搏阈值的100%安全裕度来调整起搏脉冲。降低输出的目的是延长起搏器寿命。这项前瞻性随机试验的目的是比较单腔和双腔起搏器中额定输出与较低输出对预计起搏器寿命的影响。次要目的是评估有多少患者可以被编程为2.5V/0.4ms而不是额定的3.5V设置,且安全裕度≥100%。患者接受相同类型的VVI或DDD起搏器,这些起搏器在心室中与释放类固醇的高阻抗起搏导线相连。在3个月的随访中,在2.5V脉冲幅度下心室起搏阈值≤0.15ms的患者被随机分为0.4ms脉冲持续时间下的3.5V或2.5V幅度组。在植入后6个月和12个月通过起搏器遥测评估导线功能和预计的设备寿命。在植入VVI起搏器的患者中,在3个月的随访时,3例患者在2.5V时起搏阈值>0.15ms,139例患者可以被随机分组。1例患者需要重新编程为更高的输出。在整个研究期间,心室起搏的平均百分比约为40%。编程为2.5V输出导致设备寿命从额定组的117.9±18.7个月在12个月随访时略有增加至123.7±11.9个月(P=0.16)。在植入DDD起搏器的患者中,166例患者接受了随机分组。心室起搏的平均百分比在心室中为85%,在心房中为35%。2.5V设置显著延长了起搏器寿命,从98.1±21.3个月延长至112.0±13.6个月(P<0.0001)。在3例(1%)患者中观察到起搏阈值后期升高。由于心室起搏阈值较低,植入后3个月,2.5V/0.4ms设置在99%的患者中提供了≥100%的安全裕度。与额定的3.5V设置相比,编程为较低输出略微增加了预计的起搏器寿命。单腔脉冲发生器患者的寿命增加了5%,双腔脉冲发生器患者的寿命增加了14%。